최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기The Veterinary quarterly, v.41 no.1, 2021년, pp.202 - 209
Park, Jung-Eun (Research Institute of Veterinary Medicine, Chungnam National University , Daejeon , Republic of Korea) , Shin, Hyun-Jin (Research Institute of Veterinary Medicine, Chungnam National University , Daejeon , Republic of Korea)
AbstractBackgroundRabies is a viral disease that causes severe neurological manifestations both in humans and various mammals. Although inactivated and/or attenuated vaccines have been developed and widely used around the world, there are still concerns with regard to their safety, efficacy, and cos...
Abreu-Mota T , Hagen KR , Cooper K , Jahrling PB , Tan G , Wirblich C , Johnson RF , Schnell MJ. 2018 . Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever . Nat Commun . 9 ( 1 ): 4223 . 30310067
Albertini AA , Ruigrok RW , Blondel D. 2011 . Rabies virus transcription and replication . Adv Virus Res . 79 : 1 – 22 . 21601039
Amann R , Rohde J , Wulle U , Conlee D , Raue R , Martinon O , Rziha H-J. 2013 . A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein . J Virol . 87 ( 3 ): 1618 – 1630 . 23175365
Armbruster N , Jasny E , Petsch B. 2019 . Advances in RNA vaccines for preventive indications: a case study of a vaccine against rabies . Vaccines (Basel) . 7 ( 4 ). Sep 2710.3390/vaccines7040132.
Banyard AC , Horton DL , Freuling C , Muller T , Fooks AR. 2013 . Control and prevention of canine rabies: the need for building laboratory-based surveillance capacity . Antiviral Res . 98 ( 3 ): 357 – 364 . 23603498
Baumgarth N , Herman OC , Jager GC , Brown LE , Herzenberg LA , Chen J. 2000 . B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection . J Exp Med . 192 ( 2 ): 271 – 280 . 10899913
Boes M , Esau C , Fischer MB , Schmidt T , Carroll M , Chen J. 1998 . Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM . J Immunol . 160 ( 10 ): 4776 – 4787 . 9590224
Chen T , Zhou X , Qi Y , Mi L , Sun X , Zhang S , Liu Y , Olson V , Qiu W , Wu X , et al. 2019 . Feline herpesvirus vectored-rabies vaccine in cats: a dual protection . Vaccine . 37 ( 16 ): 2224 – 2231 . 30878247
Chulasugandha P , Khawplod P , Havanond P , Wilde H. 2006 . Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children . Vaccine . 24 ( 9 ): 1478 – 1482 . 16221511
Cliquet F , Picard-Meyer E. 2004 . Rabies and rabies-related viruses: a modern perspective on an ancient disease . Rev Sci Tech . 23 ( 2 ): 625 – 642 . 15702724
Cobleigh MA , Bradfield C , Liu Y , Mehta A , Robek MD. 2012 . The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate . J Virol . 86 ( 8 ): 4253 – 4261 . 22345454
DeBuysscher BL , Scott D , Marzi A , Prescott J , Feldmann H. 2014 . Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins . Vaccine . 32 ( 22 ): 2637 – 2644 . 24631094
Diamond MS , Sitati EM , Friend LD , Higgs S , Shrestha B , Engle M. 2003 . A critical role for induced IgM in the protection against West Nile virus infection . J Exp Med . 198 ( 12 ): 1853 – 1862 . 14662909
Dong F , Li D , Wen D , Li S , Zhao C , Qi Y , Jangra RK , Wu C , Xia D , Zhang X , et al. 2019 . Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus . NPJ Vaccines . 4 ( 1 ): 5 . 30701094
Dorfmeier CL , Lytle AG , Dunkel AL , Gatt A , McGettigan JP. 2012 . Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection . J Virol . 86 ( 21 ): 11533 – 11540 . 22896601
Dorfmeier CL , Shen S , Tzvetkov EP , McGettigan JP. 2013 . Reinvestigating the role of IgM in rabies virus postexposure vaccination . J Virol . 87 ( 16 ): 9217 – 9222 . Aug 23760250
Ertl HCJ. 2019 . New rabies vaccines for use in humans . Vaccines (Basel) . 7 ( 2 ): 54 .
Finkelman FD , Holmes J , Katona IM , Urban JF , Beckmann MP , Park LS , Schooley KA , Coffman RL , Mosmann TR , Paul WE , et al. 1990 . Lymphokine control of in vivo immunoglobulin isotype selection . Annu Rev Immunol . 8 ( 1 ): 303 – 333 . 1693082
Flamand A , Raux H , Gaudin Y , Ruigrok RW. 1993 . Mechanisms of rabies virus neutralization . Virology . 194 ( 1 ): 302 – 313 . 7683158
Fooks AR , Cliquet F , Finke S , Freuling C , Hemachudha T , Mani RS , Müller T , Nadin-Davis S , Picard-Meyer E , Wilde H , et al. 2017 . Rabies . Nat Rev Dis Primers . 3 ( 1 ): 17091 . 29188797
Fooks AR , Johnson N , Brookes SM , Parsons G , McElhinney LM. 2003 . Risk factors associated with travel to rabies endemic countries . J Appl Microbiol . 94 ( Suppl ): 31 – 6S .
Hampson K , Coudeville L , Lembo T , Sambo M , Kieffer A , Attlan M , Barrat J , Blanton JD , Briggs DJ , Cleaveland S , et al. ; on behalf of the Global Alliance for Rabies Control Partners for Rabies Prevention . 2015 . Estimating the global burden of endemic canine rabies . PLoS Negl Trop Dis . 9 ( 4 ): e0003709 . 25881058
Hangartner L , Zinkernagel RM , Hengartner H. 2006 . Antiviral antibody responses: the two extremes of a wide spectrum . Nat Rev Immunol . 6 ( 3 ): 231 – 243 . 16498452
Kamoltham T , Khawplod P , Wilde H. 2002 . Rabies intradermal post-exposure vaccination of humans using reconstituted and stored vaccine . Vaccine . 20 ( 27–28 ): 3272 – 3276 . 12213396
Kamoltham T , Thinyounyong W , Phongchamnaphai P , Phraisuwan P , Khawplod P , Banzhoff A , Malerczyk C. 2007 . Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe . J Pediatr . 151 ( 2 ): 173 – 177 . 17643772
Kopf M , Brombacher F , Bachmann MF. 2002 . Role of IgM antibodies versus B cells in influenza virus-specific immunity . Eur J Immunol . 32 ( 8 ): 2229 – 2236 . 12209635
Madhusudana SN , Subha S , Thankappan U , Ashwin YB. 2012 . Evaluation of a direct rapid immunohistochemical test (dRIT) for rapid diagnosis of rabies in animals and humans . Virol Sin . 27 ( 5 ): 299 – 302 . 23055005
Marzi A , Feldmann F , Geisbert TW , Feldmann H , Safronetz D. 2015 . Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses . Emerg Infect Dis . 21 ( 2 ): 305 – 307 . 25625358
Moore SM , Hanlon CA. 2010 . Rabies-specific antibodies: measuring surrogates of protection against a fatal disease . PLoS Negl Trop Dis . 4 ( 3 ): e595e595 . 20231877
Nandi S , Kumar M. 2010 . Development in immunoprophylaxis against rabies for animals and humans . Avicenna J Med Biotechnol . 2 ( 1 ): 3 – 21 . 23407587
Park J-E , Li K , Barlan A , Fehr AR , Perlman S , McCray PB , Gallagher T Jr. 2016 . Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism . Proc Natl Acad Sci USA . 113 ( 43 ): 12262 – 12267 . 27791014
Racine R , Winslow GM. 2009 . IgM in microbial infections: taken for granted? Immunol Lett . 125 ( 2 ): 79 – 85 . 19539648
Ramya R , Mohana Subramanian B , Sivakumar V , Senthilkumar RL , Sambasiva Rao KR , Srinivasan VA. 2011 . Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice . Clin Vaccine Immunol . 18 ( 10 ): 1673 – 1679 . 21813661
Rupprecht CE , Nagarajan T , Ertl H. 2016 . Current status and development of vaccines and other biologics for human rabies prevention . Expert Rev Vaccines . 15 ( 6 ): 731 – 749 . 26796599
Schnell MJ , Johnson JE , Buonocore L , Rose JK. 1997 . Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection . Cell . 90 ( 5 ): 849 – 857 . 9298897
Smith JS , Yager PA , Baer GM. 1973 . A rapid reproducible test for determining rabies neutralizing antibody . Bull World Health Organ . 48 ( 5 ): 535 – 541 . 4544144
Snapper CM , Paul WE. 1987 . Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production . Science . 236 ( 4804 ): 944 – 947 . 3107127
Tober R , Banki Z , Egerer L , Muik A , Behmuller S , Kreppel F , Greczmiel U , Oxenius A , von Laer D , Kimpel J , et al. 2014 . VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications . J Virol . 88 ( 9 ): 4897 – 4907 . 24554655
Wang C , Dulal P , Zhou X , Xiang Z , Goharriz H , Banyard A , Green N , Brunner L , Ventura R , Collin N , et al. 2018 . A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis . PLoS Negl Trop Dis . 12 ( 10 ): e0006870 . 30372438
Wang X , Fang Z , Xiong J , Yang K , Chi Y , Tang X , Ma L , Zhang R , Deng F , Lan K , et al. 2019 . A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge . Virology . 536 : 32 – 38 . 31394410
Wu F , Fan X , Yue Y , Xiong S , Dong C. 2014 . A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis . Vaccine . 32 ( 31 ): 3917 – 3926 . 24874923
Zhu S , Guo C. 2016 . Rabies control and treatment: from prophylaxis to strategies with curative potential . Viruses . 8 ( 11 ): 279 .
Zinkernagel RM , Adler B , Holland JJ. 1978 . Cell-mediated immunity to vesicular stomatitis virus infections in mice . Expl Cell Biol . 46 ( 1-2 ): 53 – 70 .
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.